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Background and purpose   Spontaneous osteonecrosis of the knee 
(SPONK) is a painful lesion in the elderly, frequently leading to 
osteoarthritis and subsequent knee surgery. We evaluated the 
natural course and long-term consequences of SPONK in terms 
of need for major knee surgery. 
Methods   Between 1982 and 1988, 40 consecutive patients 
were diagnosed with SPONK. The short-term outcome has been 
reported previously (1991). After 1–7 years, 10 patients had a good 
radiographic outcome and 30 were considered failures, develop-
ing osteoarthritis. In 2012, all 40 of the patients were matched 
with the Swedish Knee Arthroplasty Register (SKAR) and their 
medical records were reviewed to evaluate the long-term need for 
major knee surgery.
Results   At the 2012 review, 33 of the 40 patients had died. The 
mean follow-up time from diagnosis to surgery, death, or end of 
study was 9 (1–27) years. 17 of 40 patients had had major knee 
surgery with either arthroplasty (15) or osteotomy (2). All oper-
ated patients but 1 were in the radiographic failure group and had 
developed osteoarthritis in the study from 1991. 6 of 7 patients 
with large lesions (> 40% of the AP radiographic view of the con-
dyle) at the time of the diagnosis were operated. None of the 10 
patients with a lesion of less than 20% were ever operated.
Interpretation   It appears that the size of the osteonecrotic 
lesion can be used to predict the outcome. Patients showing early 
signs of osteoarthritis or with a large osteonecrosis have a high 
risk of later major knee surgery. 

Almost 50 years ago, Ahlbäck and Bauer in Lund—together 
with the American radiologist Bohne (Ahlbäck et al. 1968)—
described a condition that they named spontaneous osteonecro-
sis of the knee (SPONK). This condition, originally described 
as a single entity, has been re-classified as 3 separate condi-
tions (Zywiel et al. 2009, Mont et al. 2011, Strauss et al. 2011): 
(1) SPONK, the subject of the present article, usually affects a 
single condyle in older patients; (2) the term secondary osteo-
necrosis is used when the condition has a known cause, such as 
corticosteroid treatment or sickle-cell anemia. Younger patients 
are more often affected, and the radiographic appearance is dif-
ferent, with lesions in multiple foci; (3) a third form, osteone-
crosis of the knee post arthroscopy, affects only one condyle 
and starts with increasing knee pain and positive MRI findings 
after arthroscopic surgery (Kraenzlin et al. 2010). 
The etiology of SPONK was—and still is—unknown, but 
2 main theories have been advanced: vascular (Kantor 1987, 
Jones 1993) and traumatic (Yamamoto and Bullough 2000, 
Akamatsu et al. 2012). SPONK can lead to subchondral col-
lapse and secondary osteoarthritis often requiring knee sur-
gery. The prognosis of the disease has been shown to depend 
on the size of the lesion (Lotke et al. 1982). 
The start of symptoms of SPONK is classically acute onset 
of pain without predisposing trauma and the most common 
finding on physical examination is localized tenderness over 
the medial femoral condyle (Lotke et al. 1982). The initial 
radiograph may be negative, especially if the symptoms are of 
short duration, and the diagnosis is therefore often missed at 
this stage. Later on, radiographs typically show a subchondral 
radiolucent lesion in the weight-bearing area of the medial 
or lateral femoral condyle (Figure 1). In some patients, the 
radiographs may remain normal during the whole course of 
the disease (Lotke et al. 1977, Houpt et al. 1983) and changes 
are only seen with bone scintigraphy or magnetic resonance 
imaging (Koshino 1982). Scintigraphy, performed within a 
few days of the onset of pain, shows a high uptake in the 
affected femoral condyle (Rozing et al. 1980). MRI shows 
bone marrow edema in the affected condyle. This and a focal 
subchondral lesion (Figure 2) are considered the cardinal 
signs for diagnosis of osteonecrosis (Björkengren et al. 1990, 
Yates et al. 2007). 
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In a previous study from the orthopedic department of Lund 
University Hospital, 40 consecutive patients with scintigraphic 
and/or radiographic signs of osteonecrosis in one of the femo-
ral condyles were followed for 1–7 years (Al-Rowaih et al. 
1991). The size of the lesion correlated with the outcome, and 
lesions equal to or larger than 40% of the involved femoral 
condyle in the AP radiograph all had a poor outcome, develop-
ing osteoarthritis. We reviewed these 40 patients 20 years later 
to determine the natural course and long-term consequences 
of untreated SPONK, in terms of need to undergo major knee 
surgery with high tibial osteotomy or arthroplasty during the 
rest of their lives.
Patients and methods
The initial study (1982–88)
Between 1982 and 1988, 40 consecutive patients (31 females) 
were diagnosed with primary osteonecrosis at the orthopedic 
department of Lund University Hospital, and they were fol-
lowed for 1–7 years with repeated plain radiography and scin-
Figure 1. An 83-year-old woman developed osteonecrosis and secondary osteoarthritis in the medial 
femur condyle. The initial radiographs at diagnosis (A) and those after 1 year (B) showed a small but 
typical radiolucent subchondral lesion in the weight-bearing area of the medial femoral condyle. The 
patient had a total knee arthroplasty 2 years after diagnosis (C).
  A
  B
  A
  B   C
Figure 2. MR image showing bone marrow edema of the medial femur 
condyle with a focal subchondral lesion typical of osteonecrosis.
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tigraphy (Al-Rowaih et al. 1991). The inclusion criteria were 
(1) rapid onset, (2) a typical localization of pain, and (3) a 
characteristic positive scintigraphy, and the exclusion criteria 
were a medical history of a disease known to cause second-
ary osteonecrosis. Mean age at onset was 67 (41–85) years. 
During the initial period of the disease, before the diagnosis 
was confirmed, 3 patients had undergone a medial meniscec-
tomy and 12 patients had received at least 1 intraarticular cor-
ticosteroid injection after the onset of symptoms. 
AP and lateral radiographs were taken during weight bear-
ing at the initial visit and at the follow-up examinations. The 
necrotic lesion was staged according to Aglietti et al. (1983). 
The size of the lesion was measured using 2 methods: (1) by 
multiplying the width of the lesion in the AP view by the depth 
in the lateral view (Muheim and Bohne 1970), and (2) by cal-
culating the width of the lesion in the AP view as a percentage 
of the affected femoral condyle (Lotke et al. 1982). The Ahl-
bäck classification (1968) was used to stage osteoarthritis if it 
already existed or was developing. 
The duration of symptoms from onset to the first radio-
graphic examination was 34 (2–240) weeks. Radiographic 
osteonecrotic changes were initally seen in 19 of the 40 
knees, and in the remaining patients changes were only seen 
by scintigraphy. A radiographic osteonecrotic lesion even-
tually developed in 33 of the 40 knees during the follow-up 
in 1982–88. 29 patients developed osteoarthritis of Ahlbäck 
grade 1 or more. 10 patients never developed osteoarthritis 
during follow-up. 1 patient had persistent pain during 3 years 
of follow-up but had no osteoarthritis on radiographs, and was 
operated with arthrotomy and drilling into the osteonecrosis. 
The 2012 follow-up
In the present study, carried out in the spring of 2012, all the 
patients from the initial study were identified and included 
to determine the incidence of further knee surgery. Informa-
tion from the Swedish Knee Arthroplasty Register (SKAR) 
was used to identify patients who had undergone reconstruc-
tive knee surgery after the publication of the initial study. The 
SKAR was started in 1975, and all hospitals performing knee 
arthroplasties in Sweden report both primary procedures and 
revision procedures to the SKAR. The coverage of the SKAR 
is 100% for the hospitals in Sweden, and 97% of Swedish 
knee arthroplasties have been shown to be included in the reg-
ister (SKAR 2010). The patients in the original study were 
matched with the SKAR more than 20 years later, and their 
medical records were reviewed for additional surgical proce-
dures including high tibial osteotomy. 
 We used Student’s t-test for statistical analysis of the age 
differences between groups.
Results
All 40 patients in the original study were identified and their 
medical journals reviewed. All arthroplasty patients were 
found in the SKAR, both with the primary surgery and, if 
applicable, the revision surgery. 33 of the 40 patients had 
died. 4 unoperated patients were still alive at the most recent 
follow-up. The mean follow-up time, from diagnosis until 
death or the end of the study, was 15 (1–30) years. The mean 
time from diagnosis to one of the 3 endpoints—knee surgery, 
death, or end of study—was 9 (1–27) years. A Kaplan-Meier 
failure estimate showing the proportion of patients needing to 
undergo knee surgery with either osteotomy or arthroplasty 
over the years was calculated (Figure 3). 
17 patients had been operated on with a unicompartmen-
tal arthroplasty (n = 6), a total knee arthroplasty (n = 9), or 
an osteotomy (n = 2) (Table). 1 patient without any radio-
graphic osteoarthritic changes at the initial study later devel-
oped osteoarthritis and was operated with a unicompartmental 
Figure 3. Kaplan-Meier failure estimate showing the proportion of 
patients requiring knee surgery with arthroplasty or high tibial oste-
otomy over the years.
Radiographic outcome and surgical procedures in the initial study 
and the present study. Outcome of the 40 patients at early and late 
time points. 10 of the 40 patients were considered to have good 
outcome in terms of not developing osteoarthritis in the initial study, 
and the other 30 were considered failures (Al-Rowaih et al. 1991). At 
the latest follow-up, 15 patients had undergone knee arthroplasty, 
14 in the group with initial osteoarthritis and 1 in the group without. 
2 more patients had been operated with an osteotomy
Radiographic  Arthroplasty Osteotomy Arthroplasty Osteotomy
outcome a 1988 1988 2012 2012
Good (n = 10) 0 0 1 0
Failure (n = 30) 8 4 b  14 2 b
a
 Radiographic outcome in the initial 1988 study (Al-Rowaih 1991)
b
 2 patients who were operated with osteotomy were later revised to 
arthroplasty.
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arthroplasty 9 years after onset of symptoms. Except for this 
patient, all the patients who underwent major surgery were 
in the “failure” group, developing osteoarthritis in the initial 
study (1991) with an original Lotke index of ≥ 20. Six of 7 
patients with an initial Lotke index of ≥ 40 were eventually 
operated with a knee prosthesis. None of the the initial study 
patients in which the lesion was visible only by scintigraphy 
but not by radiography were ever operated. None of the 10 
patients with a lesion of less than 20% were ever operated. 
The median time to knee surgery was 1.5 (0.5–11) years and 
14 out of 17 of the operations were carried out in the first 4 
years. However, one patient had surgery 11 years after onset 
of symptoms (Figure 3). 
The mean age of the patients who were operated with knee 
prosthesis or osteotomy was 68 (48–85) years at the start of 
symptoms, as compared to 74 (64–84) in the group that had 
been considered to be failures in the initial study but that had 
never been operated (p = 0.1). The mean age of the 10 patients 
with a “good” outcome, who did not develop OA in the initial 
study, was 56 (41–77) years, as compared to 71 (48–85) years 
in the group that developed OA (p < 0.001). No gender-related 
differences could be found regarding the need to undergo sur-
gery with a knee prosthesis.
Discussion
The mean follow-up time from diagnosis to death or end of 
the study was 15 (1–27) years. Previous studies on SPONK 
have all had shorter mean follow-up periods, ranging from 2.8 
to 5.6 years (Rozing et al. 1980, Lotke et al. 1982, Haupt et 
al. 1983, Al-Rowaih et al. 1991, Satku et al. 2003). Rozing et 
al. (1980) reported the largest series, in which 35 of 90 knees 
with SPONK were treated with osteotomy or arthroplasty. 
The size of the lesion has classically been regarded as 
being prognostic, with an increased risk of osteoarthritis with 
increasing size (Lotke et al. 1982). In the early follow-up of 
the present series (Al-Rowaih et al. 1991), a cut-off value 
could be defined: if 40% of the joint surface was affected in 
the AP view, the patient developed osteoarthritis. 17 of the 
40 patients in the 2012 follow-up had been operated, 15 with 
arthroplasty and 2 with osteotomy. Patients with a good out-
come in the initial 1- to 7-year follow-up continued to do well 
in this long-term follow-up. Only 1 patient without any radio-
graphic osteoarthritic changes in the initial study deteriorated, 
and was operated after 9 years. Most surgeries were done 
during the first years, and if the patient had a small lesion or 
did not develop OA during this early time period, it appeared 
less likely that a late deterioration would occur. 
Limitations of the study
Bisphosphonates were introduced in clinical practice for the 
treatment of osteoporosis in the mid- 1990s in Sweden, after 
the publication by al-Rowaih et al. (1991). No evidence was 
found in the medical records that any of the patients were 
treated with bisphosphonates after this, but it cannot be ruled 
out that some patients may have been treated due to osteoporo-
sis—which might have influenced the outcome. Furthermore, 3 
patients had undergone medial meniscectomy before diagnosis 
of SPONK. Post-arthroscopic osteonecrosis is a rare event, and 
this entity may have a better prognosis than the primary idio-
pathic SPONK (Kraenzlin et al. 2010), but it was not described 
at the time of the initial study. 2 of the 3 patients who had 
undergone an arthroscopy before the SPONK diagnosis had a 
good outcome, with no development of osteoarthritis. 
Treatment options today involve both non-surgical and sur-
gical methods such as pulsed electromagnetic fields (PEMFs) 
therapy (Marcheggiani et al. 2013), restricted weight bear-
ing, core decompression, osteochondral autograft transfer, 
and knee artroplasty (Zywiel et al. 2009, Duany et al. 2010, 
Strauss et al. 2011). No randomized or high-quality studies 
comparing different treatment options have been published. 
Systemic treatment with bisphosphonates has been suggested 
to postpone the resorption of the necrotic bone during the 
revascularization and new bone formation. Bisphosphonates 
have delayed the resorption of revascularizing dead bone 
experimentally (Åstrand and Aspenberg 2002, Little et al. 
2003, Tägil et al. 2004, Kim et al. 2005) as well as in clinical 
hip osteonecrosis case series (Agarwala et al. 2005, Nishii et 
al. 2006, Ramachandran et al. 2007) and knee osteonecrosis 
series (Kraenzlin et al. 2010). In the only randomized human 
study, bisphosphonates in patients with femoral head osteone-
crosis substantially reduced the risk of secondary osteoarthri-
tis and hip arthroplasty (Lai et al. 2005). Our group has pub-
lished a prospective case series of 17 patients with SPONK, 
in which systemic bisphosponate treatment appeared to 
reduce the risk of developing severe osteoarthritis compared 
to the early results of the present series. Only 2 of 17 of these 
bisphosphonate-treated patients were operated with major 
knee surgery during the 1- to 4-year follow-up (Juréus et al. 
2012), as compared to 12 of 40 in the present untreated series 
at a similar follow-up time (Al-Rowaih et al. 1991). 
In the present series the morbidity of a SPONK was sub-
stantial, and treatment to prevent development of osteoarthi-
tis is warranted. Patients with large osteonecrosis (> 40% of 
the affected condyle) or early signs of osteoarthritis have a 
high risk of undergoing major knee surgery. At present, these 
patients should be considered for early major knee surgery but 
the results of randomized studies with bisphosphonates may 
change the number of treatment options. 
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